SDHD-related chromaffin tumours: disease localisation to genetic dysfunction
U Srirangalingam1, B Khoo, M Matson
1Department of Endocrinology, St Bartholomew's Hospital, London, UK. u.srirangalingam@qmul.ac.uk
A novel succinate dehydrogenase D (SDHD) mutation was identified in a patient with multiple chromaffin tumors. Surgical removal cured the patient, highlighting the importance of genetic testing for these rare tumors.
Area of Science:
- Endocrinology
- Genetics
- Oncology
Background:
- Pheochromocytomas and paragangliomas are rare neuroendocrine tumors arising from chromaffin cells.
- Genetic mutations, particularly in succinate dehydrogenase (SDH) genes, are implicated in the development of these tumors.
- Early diagnosis and genetic screening are crucial for effective management and familial risk assessment.
Observation:
- A 15-year-old male presented with severe hypertension and elevated urinary catecholamines, initially suspected to be bilateral adrenal pheochromocytomas.
- Adrenal venous sampling confirmed a right adrenal pheochromocytoma and a distinct left abdominal paraganglioma.
- Surgical excision of both tumors resulted in a cure without the need for long-term steroid replacement.
Findings:
- Genetic analysis revealed a novel SDHD mutation (c. 169 + 1 G>A), predicted to cause loss of the 5' splice site and exon 2 exclusion.
- This mutation is considered likely pathogenic, contributing to the development of the chromaffin tumors.
- Ongoing surveillance and genetic screening of first-degree relatives are being conducted.
Implications:
- Genetic testing for SDHD mutations should be considered in all patients with chromaffin tumors.
- Adrenal venous sampling can aid in clarifying diagnostic uncertainty in complex cases.
- Multidisciplinary team involvement is essential for managing patients with complex chromaffin tumor presentations and genetic mutations.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Huntington Disease l: Introduction
Mutations
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Karyotyping
Genetic Lingo
